 Home > Active Ingredient News > Antitumor Therapy > Front Oncol: The effect of chemotherapy on the prognosis of patients with stage I nasopharyngeal carcinoma

Front Oncol: The effect of chemotherapy on the prognosis of patients with stage I nasopharyngeal carcinoma

 Last Update: 2021-10-19
 Source: Internet
 Author: User

Tags

1 2 3 trimethylbenzene

1 3 dioxolane

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Radiotherapy and chemotherapy are recommended for stage II and locally advanced nasopharyngeal carcinoma

The study extracts relevant data of stage I nasopharyngeal carcinoma patients from 2010 to 2015 from the SEER database

A total of 226 patients were enrolled

Clinical features

Before PSM, the 3-year OS (74.

Comparison of prognosis before PSM

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.

Factors related to prognosis before PSM

Similarly, in the PSM matched cohort, 5-year OS (63.

Comparison of prognosis after PSM

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.
55, 95% CI: 1.
08-6.
00; P = 0.
032) and CSS (HR = 5.
87, 95% CI: 1.
14-30.
28; P = 0.
035) Factors
.

Prognostic factors after PSM

In summary, studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.
Studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.
Studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.

Original source:

Ma JL, Huang ST, Jiang YM and Pan XB (2021) Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma.
Front.
Oncol.
11:735817.
doi: 10.
3389/fonc.
2021.
735817

.
.
Ma JL, Huang ST, Jiang YM and Pan XB (2021) Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma Front Oncol 11:.
735817 doi:.
10.
3389 / fonc.
2021.
735817

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.